Publication | Closed Access
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
43
Citations
20
References
2022
Year
VEN combined with HMA was effective with R/R AML patients, and the response to treatment was associated with genetic characteristics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1